The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
<h3>Background</h3><p dir="ltr">Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this st...
Saved in:
| Main Author: | Alison J. Dawson (18175003) (author) |
|---|---|
| Other Authors: | Thozhukat Sathyapalan (704787) (author), Rebecca Vince (17023392) (author), Anne-Marie Coady (18140278) (author), Ramzi A. Ajjan (3617486) (author), Eric S. Kilpatrick (6684365) (author), Stephen L. Atkin (6684368) (author) |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
by: Richard J. Kirk (18174919)
Published: (2019) -
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
by: Abdelilah Arredouani (10914455)
Published: (2025) -
Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
by: Abu Saleh Md Moin (6189512)
Published: (2021) -
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021) -
Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
by: Abu Saleh Md Moin (6189512)
Published: (2021)